Conference with accompanying exhibition
Technologies for Immuno-Oncology                                                                                             

Wednesday, April 3, 2019

9:30 - 18:00

TranslaTUM - Center for Translational Cancer Research, Einsteinstraße 25, 81675 Munich 

The event is presented in cooperation with TranslaTUM – Center for Translational Cancer Research, and BioM Biotech Cluster Development GmbH.

The event is sponsored by Bristol-Myers Squibb.

Brochure of the event

Registration: Please register via our Online-Shop 


• Biovariance GmbH • Bristol-Myers Squibb GmbH & Co. KGaA • Cenibra GmbH • Dynamic Biosensors GmbH • Eurofins Genomics Europe Shared Services GmbH • HOT Screen GmbH • Miltenyi Biotec GmbH • Ovizio Imaging Systems NV/SA • PromoCell GmbH • Sartorius Lab Instruments GmbH & Co. KG
Exhibition: Registration for exhibitors

Participation Fee: Members of Forum MedTech Pharma e.V.: 160 €, Non-members Research & Clinics: 240 €,
Non-members Industry 320 €  
(plus VAT 7%)

Concept and Organisation: Forum MedTech Pharma e.V.

Contact Person: Dr. Monika Mügschl-Scharf (

Cancellations received before March 27, 2019 are exempt from charges. For later cancellations and for non-attendance, the full amount will be incurred. Your address data is only used internally by Forum MedTech Pharma e.V.


Immunotherapies against cancer open up completely new opportunities to fight this emperor of all maladies“. But for this kind of therapies to become widely applied and successful, technological hurdles have yet to be overcome.

For one, meaningful biomarkers must be identified, for patient stratification as well as for monitoring therapeutic success. On the other hand, some immuno-therapeutics are not the usual kind of drugs. They are so-called Advanced Therapy Medicinal Products (ATMPs), and their production, quality & security control and delivery to the patient are especially challenging.

At the Conference Technologies for Immuno-Oncology“, researchers, clinicians and companies will show approaches to tackle those challenges. The importance of translational research in unleashing the potential of those novel strategies to fight cancer will be highlighted.

In the afternoon of the conference day, attendees will have the opportunity to visit the research facilities at the TranslaTUM - Center for Translational Cancer Research, including the Core Facilities Imaging, Preclinical Research and Cell Analysis. TranslaTUM staff will be available for Q&As by the participants during a “Meet the Scientists” session. Company demonstrators as well as an accompanying exhibition will showcase technological innovations for immuno-oncology.

 Images: fotolia/DesignCells, fotolia/sommart, TranslaTUM

Zeit Referent Titel
from 8:30    Registration & Welcome Coffee
09:30 Dr. Monika Mügschl-Scharf
Forum MedTech Pharma e.V., Nürnberg

Prof. Dr. Oliver Hayden
TranslaTUM - Center for Translational Cancer Research, Munich

(only for participants and members, PDF 1.1 MB)

Welcome TranslaTUM

(only for participants and members, PDF 1.1 MB)

10:00 Prof. Dr. med. Jürgen Ruland
Department of Clinical Chemistry, Technische Universität München

KEYNOTE: Immune Signals in Cancer

Biomarkers for Immuno-Oncology

10:30 Prof. Dr. Wolfgang Weber
Department of Nuclear Medicine, Klinikum rechts der Isar, Munich

PET Imaging in Immunotherapy

10:55 Dr. Holger Krönig
Medical Director Oncology, Bristol-Myers Squibb GmbH & Co. KGaA, Munich

KEYNOTE: Biomarkers for Immuno-Oncology

11:25 - 12:00 Coffee Break

Cell Engineering & Analysis

12:00 Dr. Ram Shankar
Manager R&D, PlasmidFactory GmbH & Co. KG, Bielefeld
Minicircle DNA – New Tool for Cell Therapy

(download only for participants and members, PDF 1 MB)

12:25 Prof. Dr. med. Dirk Busch
Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München
Engineering of T-Cells for Adoptive Immunotherapy

(download only for participants and members, PDF 14.3 MB)

12:50 • Progressing 3D Spheroid Analysis into a HTS Drug Discovery Method, Dr. Illip Burmester, Cenibra GmbH, Bramsche
• Binding analysis of bispecific antibodies for targeted tumor engagement, Dr. Ulrich Rant, Dynamic Biosensors GmbH, Martinsried
The DNA Universe - Genomic Services for Your Clinical Studies and Research, Dr. Bernhard Busch, Eurofins Genomics Germany GmbH, Ebersberg
• Organotypical profiling of Checkpoint Inhibitors Using Human High-End Whole Blood Culture Models, Dr. Manfred Schmolz, HOT Screen GmbH, Reutlingen
Label-free and In-line CAR-T Monitoring in Bioreactor, Emilie Viey / Serge Jooris, Ovizio Imaging Systems NV/SA, Brussels (BEL)
• Innovative Solutions for Cell Culture Research and Cell Line Development, Marlene Posch-Devedzic, Sartorius Lab Instruments GmbH & Co. KG, Göttingen 

Exhibitor Pitch Session: 
Technologies for Immuno-Oncology

Dynamic Biosensors GmbH

Eurofins Genomics Europe Shared Services GmbH

HOT Screen GmbH

Ovizio Imaging Systems NV/SA

Sartorius Lab Instruments GmbH & Co. KG

(download only for participants and members, PDF 0.6 MB)

13:15 - 14:15 Lunch Break

Cell Production & Realisation of Therapies

14:15 Dr. Klaus Kühlcke
Managing Director, BioNTech Innovative Manufacturing Services GmbH, Idar-Oberstein
14:40 Dr. Andrew Kaiser
R&D Manager Immunotherapy and Gene-Engineering, Miltenyi Biotec GmbH, Bergisch Gladbach
A Cell Factory and Automated Manufacturing Platforms Serving Cellular Therapies

(download only for participants and members, PDF 4.9 MB)

15:05 Dr. Tobias Ostler
Associate Director Regulatory Compliance, SYNLAB Analytics & Services Switzerland AG, Birsfelden (CH)
ATMP Development: the Expectations of the Regulatory Agencies

(download only for participants and members, PDF 0.5 MB)

15:30 - 16:00 Coffee Break

16:00 Dr. Niklas Münchmeier
Medical Manager Cell & Gene Therapy, Novartis Pharma GmbH, Nuremberg

KEYNOTE: CAR-T Cell Immunotherapy in Leukemias and Lymphomas – From Research to Market

Interaction time (16:30 – 17:15 in parallel - your options)

• Company Demonstrators:

Cenibra GmbH, Bramsche 
o Miltenyi Biotec GmbH, Bergisch Gladbach
o Ovizio Imaging Systems NV/SA, Brussels (BEL) 

• Visit of TranslaTUM Research Facilities

• Meet-the-Scientists


Wrap-Up & Closing Remarks

from 17:30 Get-together